{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:37:43Z","timestamp":1790447863542,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI033144"],"award-info":[{"award-number":["AI033144"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI048793"],"award-info":[{"award-number":["AI048793"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00439-017-1768-9","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:26:05Z","timestamp":1489364765000},"page":"421-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine"],"prefix":"10.1007","volume":"136","author":[{"given":"Iana H.","family":"Haralambieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth R.","family":"Larrabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Schaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"1768_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1101\/gr.133744.111","volume":"22","author":"S Anders","year":"2012","unstructured":"Anders S, Reyes A, Huber W (2012) Detecting differential usage of exons from RNA-seq data. Genome Res 22:2008\u20132017. doi:10.1101\/gr.133744.111","journal-title":"Genome Res"},{"key":"1768_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0006-3495(01)76033-X","volume":"80","author":"AR Atilgan","year":"2001","unstructured":"Atilgan AR, Durell SR, Jernigan RL, Demirel MC, Keskin O, Bahar I (2001) Anisotropy of fluctuation dynamics of proteins with an elastic network model. Biophys J 80:505\u2013515. doi:10.1016\/S0006-3495(01)76033-X","journal-title":"Biophys J"},{"key":"1768_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/aje\/kwv320","volume":"184","author":"RA Bednarczyk","year":"2016","unstructured":"Bednarczyk RA, Orenstein WA, Omer SB (2016) Estimating the number of measles-susceptible children and adolescents in the United States Using data from the national immunization survey-teen (NIS-teen). Am J Epidemiol 184:148\u2013156. doi:10.1093\/aje\/kwv320","journal-title":"Am J Epidemiol"},{"key":"1768_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/viro.1996.0122","volume":"217","author":"CJ Buchholz","year":"1996","unstructured":"Buchholz CJ, Gerlier D, Hu A, Cathomen T, Liszewski MK, Atkinson JP, Cattaneo R (1996a) Selective expression of a subset of measles virus receptor-competent CD46 isoforms in human brain. Virology 217:349\u2013355","journal-title":"Virology"},{"key":"1768_CR5","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1128\/jvi.70.6.3716-3723.1996","volume":"70","author":"CJ Buchholz","year":"1996","unstructured":"Buchholz CJ, Schneider U, Devaux P, Gerlier D, Cattaneo R (1996b) Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. Virology 70:3716\u20133723","journal-title":"Virology"},{"key":"1768_CR6","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1128\/JVI.78.9.4385-4388.2004","volume":"78","author":"R Cattaneo","year":"2004","unstructured":"Cattaneo R (2004) Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens\u2019 magnet. J Virol 78:4385\u20134388","journal-title":"J Virol"},{"key":"1768_CR7","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1371\/journal.pcbi.0030172","volume":"3","author":"C Chennubhotla","year":"2007","unstructured":"Chennubhotla C, Bahar I (2007) Signal propagation in proteins and relation to equilibrium fluctuations. PLoS Comput Biol 3:1716\u20131726. doi:10.1371\/journal.pcbi.0030172","journal-title":"PLoS Comput Biol"},{"key":"1768_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/CVI.05652-11","volume":"19","author":"HD Clifford","year":"2012","unstructured":"Clifford HD, Hayden CM, Khoo SK, Zhang G, Le Souef PN, Richmond P (2012) CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive Australian children. Clin Vaccine Immunol 19:704\u2013710","journal-title":"Clin Vaccine Immunol"},{"key":"1768_CR9","doi-asserted-by":"publisher","first-page":"e1000766","DOI":"10.1371\/journal.pgen.1000766","volume":"5","author":"J Coulombe-Huntington","year":"2009","unstructured":"Coulombe-Huntington J, Lam KC, Dias C, Majewski J (2009) Fine-scale variation and genetic determinants of alternative splicing across individuals. PLoS Genet 5:e1000766. doi:10.1371\/journal.pgen.1000766","journal-title":"PLoS Genet"},{"key":"1768_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","volume":"120","author":"N Dhiman","year":"2007","unstructured":"Dhiman N, Cunningham JM, Jacobson RM, Vierkant RA, Wu Y, Ovsyannikova IG, Pankratz VS, Poland GA (2007) Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 120:666\u2013672","journal-title":"J Allergy Clin Immunol"},{"key":"1768_CR11","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.3129","volume":"46","author":"B Feenstra","year":"2014","unstructured":"Feenstra B, Pasternak B, Geller F, Carstensen L, Wang T, Huang F, Eitson JL, Hollegaard MV, Svanstrom H, Vestergaard M, Hougaard DM, Schoggins JW, Jan LY, Melbye M, Hviid A (2014) Common variants associated with general and MMR vaccine-related febrile seizures. Nat Genet 46:1274\u20131282. doi:10.1038\/ng.3129","journal-title":"Nat Genet"},{"key":"1768_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1101\/gr.083477.108","volume":"19","author":"HB Fraser","year":"2009","unstructured":"Fraser HB, Xie X (2009) Common polymorphic transcript variation in human disease. Genome Res 19:567\u2013575. doi:10.1101\/gr.083477.108","journal-title":"Genome Res"},{"key":"1768_CR13","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1002\/eji.200939392","volume":"39","author":"A Fuchs","year":"2009","unstructured":"Fuchs A, Atkinson JP, Fremeaux-Bacchi V, Kemper C (2009) CD46-induced human Treg enhance B-cell responses. Eur J Immunol 39:3097\u20133109. doi:10.1002\/eji.200939392","journal-title":"Eur J Immunol"},{"key":"1768_CR14","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1016\/j.vaccine.2011.08.083","volume":"29","author":"IH Haralambieva","year":"2011","unstructured":"Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz SV, Jacobson RM, Poland GA (2011a) Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine 29:7883\u20137895","journal-title":"Vaccine"},{"key":"1768_CR15","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","volume":"29","author":"IH Haralambieva","year":"2011","unstructured":"Haralambieva IH, Ovsyannikova IG, O\u2019Byrne M, Pankratz VS, Jacobson RM, Poland GA (2011b) A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine 29:4485\u20134491","journal-title":"Vaccine"},{"key":"1768_CR16","doi-asserted-by":"publisher","first-page":"8988","DOI":"10.1016\/j.vaccine.2011.09.043","volume":"29","author":"IH Haralambieva","year":"2011","unstructured":"Haralambieva IH, Ovsyannikova IG, Umlauf BJ, Vierkant RA, Pankratz SV, Jacobson RM, Poland GA (2011c) Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine 29:8988\u20138997","journal-title":"Vaccine"},{"key":"1768_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1586\/erv.12.134","volume":"12","author":"IH Haralambieva","year":"2013","unstructured":"Haralambieva IH, Ovsyannikova IG, Pankratz VS, Kennedy RB, Jacobson RM, Poland GA (2013) The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches. Expert Rev Vaccines 12:57\u201370. doi:10.1586\/erv.12.134","journal-title":"Expert Rev Vaccines"},{"key":"1768_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molmed.2015.10.005","volume":"21","author":"IH Haralambieva","year":"2015","unstructured":"Haralambieva IH, Kennedy RB, Ovsyannikova IG, Whitaker JA, Poland GA (2015) Variability in humoral immunity to measles vaccine: new developments. Trends Mol Med 21:789\u2013801. doi:10.1016\/j.molmed.2015.10.005","journal-title":"Trends Mol Med"},{"key":"1768_CR19","doi-asserted-by":"publisher","first-page":"e0160970","DOI":"10.1371\/journal.pone.0160970","volume":"11","author":"IH Haralambieva","year":"2016","unstructured":"Haralambieva IH, Zimmermann MT, Ovsyannikova IG, Grill DE, Oberg AL, Kennedy RB, Poland GA (2016) Whole transcriptome profiling identifies CD93 and other plasma cell survival factor genes associated with measles-specific antibody response after vaccination. PLoS One 11:e0160970. doi:10.1371\/journal.pone.0160970","journal-title":"PLoS One"},{"key":"1768_CR20","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1371\/journal.pgen.0030099","volume":"3","author":"J Hull","year":"2007","unstructured":"Hull J, Campino S, Rowlands K, Chan MS, Copley RR, Taylor MS, Rockett K, Elvidge G, Keating B, Knight J, Kwiatkowski D (2007) Identification of common genetic variation that modulates alternative splicing. PLoS Genet 3:e99. doi:10.1371\/journal.pgen.0030099","journal-title":"PLoS Genet"},{"issue":"Pt 1","key":"1768_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/bj3040169","volume":"304","author":"K Iwata","year":"1994","unstructured":"Iwata K, Seya T, Ueda S, Ariga H, Nagasawa S (1994) Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). Biochem J 304(Pt 1):169\u2013175","journal-title":"Biochem J"},{"key":"1768_CR22","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.vaccine.2012.01.025","volume":"30","author":"RB Kennedy","year":"2012","unstructured":"Kennedy RB, Ovsyannikova IG, Haralambieva IH, O\u2019Byrne MM, Jacobson RM, Pankratz VS, Poland GA (2012a) Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine 30:2159\u20132167","journal-title":"Vaccine"},{"key":"1768_CR23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00439-012-1179-x","volume":"131","author":"RB Kennedy","year":"2012","unstructured":"Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Jacobson RM, Poland GA (2012b) Genome-wide genetic associations with IFNgamma response to smallpox vaccine. Hum Genet 131:1433\u20131451","journal-title":"Hum Genet"},{"key":"1768_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00439-012-1174-2","volume":"131","author":"RB Kennedy","year":"2012","unstructured":"Kennedy RB, Ovsyannikova IG, Shane PV, Haralambieva IH, Vierkant RA, Poland GA (2012c) Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet 131:1403\u20131421","journal-title":"Hum Genet"},{"key":"1768_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jiu553","volume":"211","author":"ND Lambert","year":"2015","unstructured":"Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankrantz VS, Poland GA (2015) Polymorphisms in HLA-DPB1 are associated with differences in rubella-specific humoral immunity after vaccination. J Infect Dis 211:898\u2013905","journal-title":"J Infect Dis"},{"key":"1768_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature12531","volume":"501","author":"T Lappalainen","year":"2013","unstructured":"Lappalainen T, Sammeth M, Friedlander MR, t Hoen PA, Monlong J, Rivas MA, Gonzalez-Porta M, Kurbatova N, Griebel T, Ferreira PG, Barann M, Wieland T, Greger L, van Iterson M, Almlof J, Ribeca P, Pulyakhina I, Esser D, Giger T, Tikhonov A, Sultan M, Bertier G, MacArthur DG, Lek M, Lizano E, Buermans HP, Padioleau I, Schwarzmayr T, Karlberg O, Ongen H, Kilpinen H, Beltran S, Gut M, Kahlem K, Amstislavskiy V, Stegle O, Pirinen M, Montgomery SB, Donnelly P, McCarthy MI, Flicek P, Strom TM, Lehrach H, Schreiber S, Sudbrak R, Carracedo A, Antonarakis SE, Hasler R, Syvanen AC, van Ommen GJ, Brazma A, Meitinger T, Rosenstiel P, Guigo R, Gut IG, Estivill X, Dermitzakis ET (2013) Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501:506\u2013511. doi:10.1038\/nature12531","journal-title":"Nature"},{"key":"1768_CR27","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1016\/S0021-9258(17)34127-3","volume":"269","author":"MK Liszewski","year":"1994","unstructured":"Liszewski MK, Tedja I, Atkinson JP (1994) Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 269:10776\u201310779","journal-title":"J Biol Chem"},{"key":"1768_CR28","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1073\/pnas.91.6.2161","volume":"91","author":"M Manchester","year":"1994","unstructured":"Manchester M, Liszewski MK, Atkinson JP, Oldstone MBA (1994) Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci USA 91:2161\u20132165","journal-title":"Proc Natl Acad Sci USA"},{"key":"1768_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ni810","volume":"3","author":"JC Marie","year":"2002","unstructured":"Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B (2002) Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 3:659\u2013666. doi:10.1038\/ni810","journal-title":"Nat Immunol"},{"key":"1768_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2344","volume":"9","author":"MI McCarthy","year":"2008","unstructured":"McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356\u2013369","journal-title":"Nat Rev Genet"},{"key":"1768_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nsmb.1967","volume":"18","author":"CK Navaratnarajah","year":"2011","unstructured":"Navaratnarajah CK, Oezguen N, Rupp L, Kay L, Leonard VH, Braun W, Cattaneo R (2011) The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol 18:128\u2013134","journal-title":"Nat Struct Mol Biol"},{"key":"1768_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000331585","volume":"72","author":"IG Ovsyannikova","year":"2011","unstructured":"Ovsyannikova IG, Haralambieva IH, Vierkant RA, O\u2019Byrne MM, Jacobson RM, Poland GA (2011a) The association of CD46, SLAM, and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses\u2014a replication study and examination of novel polymorphisms. Hum Hered 72:206\u2013223","journal-title":"Hum Hered"},{"key":"1768_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00439-011-0977-x","volume":"130","author":"IG Ovsyannikova","year":"2011","unstructured":"Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Poland GA (2011b) The role of polymorphisms in toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 130:547\u2013561","journal-title":"Hum Genet"},{"key":"1768_CR34","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.vaccine.2012.01.038","volume":"30","author":"IG Ovsyannikova","year":"2012","unstructured":"Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA (2012) Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine 30:2146\u20132152","journal-title":"Vaccine"},{"key":"1768_CR35","doi-asserted-by":"publisher","first-page":"e1001122","DOI":"10.1371\/journal.ppat.1001122","volume":"6","author":"BD Persson","year":"2010","unstructured":"Persson BD, Schmitz NB, Santiago C, Zocher G, Larvie M, Scheu U, Casasnovas JM, Stehle T (2010) Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog 6:e1001122. doi:10.1371\/journal.ppat.1001122","journal-title":"PLoS Pathog"},{"key":"1768_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.vaccine.2011.11.085","volume":"30","author":"GA Poland","year":"2012","unstructured":"Poland GA, Jacobson RM (2012) The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines? Vaccine 30:103\u2013104","journal-title":"Vaccine"},{"key":"1768_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1084\/jem.174.1.93","volume":"174","author":"TW Post","year":"1991","unstructured":"Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP (1991) Membrane cofactor protein of the complement system: alternative splicing of serine\/threonine\/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174:93\u2013102","journal-title":"J Exp Med"},{"key":"1768_CR38","unstructured":"Prevention CfDCa (2015) Measles Cases and Outbreaks. http:\/\/www.cdc.gov\/measles\/cases-outbreaks.html. http:\/\/www.cdc.gov\/measles\/cases-outbreaks.html. Accessed 12 Feb 2015"},{"key":"1768_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725\u2013738. doi:10.1038\/nprot.2010.5","journal-title":"Nat Protoc"},{"key":"1768_CR40","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/eji.1830220625","volume":"22","author":"SM Russell","year":"1992","unstructured":"Russell SM, Sparrow RL, McKenzie IFC, Purcell DFJ (1992) Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 22:1513\u20131518","journal-title":"Eur J Immunol"},{"key":"1768_CR41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nsmb.1726","volume":"17","author":"C Santiago","year":"2010","unstructured":"Santiago C, Celma ML, Stehle T, Casasnovas JM (2010) Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol 17:124\u2013129. doi:10.1038\/nsmb.1726","journal-title":"Nat Struct Mol Biol"},{"key":"1768_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481\u2013485","journal-title":"Nature"},{"key":"1768_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209\u2013213","journal-title":"Nat Genet"},{"key":"1768_CR44","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/S0264-410X(00)00468-0","volume":"19","author":"PL Tan","year":"2001","unstructured":"Tan PL, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz SV (2001) Twin studies of immunogenicity\u2014determining the genetic contribution to vaccine failure. Vaccine 19:2434\u20132439","journal-title":"Vaccine"},{"key":"1768_CR45","volume-title":"R: a language for statistical computing","author":"RDC Team","year":"2009","unstructured":"Team RDC (2009) R: a language for statistical computing. R Foundation for Statistical Computing, Vienna"},{"key":"1768_CR46","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.4049\/jimmunol.164.4.1839","volume":"164","author":"G Wang","year":"2000","unstructured":"Wang G, Liszewski MK, Chan AC, Atkinson JP (2000) Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J Immunol 164:1839\u20131846","journal-title":"J Immunol"},{"key":"1768_CR47","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1016\/j.vaccine.2014.06.088","volume":"32","author":"JA Whitaker","year":"2014","unstructured":"Whitaker JA, Poland GA (2014) Measles and mumps outbreaks in the United States: think globally, vaccinate locally. Vaccine 32:4703\u20134704. doi:10.1016\/j.vaccine.2014.06.088","journal-title":"Vaccine"},{"key":"1768_CR48","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.4049\/jimmunol.1100159","volume":"186","author":"SA Wiltshire","year":"2011","unstructured":"Wiltshire SA, Leiva-Torres GA, Vidal SM (2011) Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis. J Immunol 186:6398\u20136405. doi:10.4049\/jimmunol.1100159","journal-title":"J Immunol"},{"key":"1768_CR49","doi-asserted-by":"publisher","first-page":"12347","DOI":"10.1073\/pnas.0902159106","volume":"106","author":"L Yang","year":"2009","unstructured":"Yang L, Song G, Jernigan RL (2009) Protein elastic network models and the ranges of cooperativity. Proc Natl Acad Sci USA 106:12347\u201312352. doi:10.1073\/pnas.0902159106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1768_CR50","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/gb-2013-14-7-r74","volume":"14","author":"K Zhao","year":"2013","unstructured":"Zhao K, Lu ZX, Park JW, Zhou Q, Xing Y (2013) GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data. Genome Biol 14:R74. doi:10.1186\/gb-2013-14-7-r74","journal-title":"Genome Biol"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-017-1768-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-017-1768-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-017-1768-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:58:59Z","timestamp":1744160339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-017-1768-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1007\/s00439-017-1768-9","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"assertion":[{"value":"3 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co. Inc., CSL Biotherapies, Avianax, Dynavax, Novartis Vaccines and Therapeutics, Emergent Biosolutions, Adjuvance, Microdermis, Seqirus, NewLink, Protein Sciences, GSK Vaccines, and Sanofi Pasteur. Drs. Poland and Ovsyannikova hold three patents related to measles and vaccinia peptide research. Dr. Kennedy has received funding from Merck Research Laboratories to study waning immunity to measles and mumps after immunization with MMR-II\n                      \u00ae\n                      . These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}